Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Pharmaceutical-Based Cargo Security and Theft Prevention

August 2, 2012

Pharmaceutical Technology

The author discusses strategies for preventing cargo theft.

Drug Delivery Insights: Nanotechnology and Microspheres

August 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments.

Medicines Top EU's Counterfeit List

July 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European Union customs in 2011.

AstraZeneca Restructures Vaccines R&D and Operations

July 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

MedImmune, the global biologics arm of AstraZeneca, announced that it is restructuring its infectious disease and vaccines R&D and operations. This will result in the closure of MedImmune's sites in Mountain View and Santa Clara, California.

Sandoz Completes Acquisition of Generic Dermatology Company Fougera for $1.5 billion

July 23, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Sandoz announced it has completed the acquisition of Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.5 billion.

A Look into the Future: The Pharmaceutical Company of 2020

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.

Biosimilars: Market Weaknesses and Strengths

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?

Decades of Change for the Top Pharmaceutical Companies

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Tracking change from spinoffs of chemical companies to life-sciences powerhouses.

Congress Passes Generic Drug Act

July 10, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

On July 9, 2012, Congress passed the Generic Drug User Fee Act in an effort to expedite the process of bringing generic drugs to market. The Act authorizes the collection of user fees from generic-drug manufacturing companies for the first time in the industry's history.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here